Company Filing History:
Years Active: 2006-2008
Title: Karen J MacFarlane: Innovator in Pharmaceutical Development
Introduction
Karen J MacFarlane is a notable inventor based in San Diego, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit IKK, a key target in various therapeutic areas. With a total of two patents to her name, her work has the potential to impact the treatment of numerous conditions.
Latest Patents
Karen's latest patents focus on anilinopyrimidine derivatives as IKK inhibitors. These compounds are designed to inhibit IKK-2, which plays a crucial role in inflammatory responses. The patents detail the structure of these compounds and their utility in treating a wide range of conditions that respond to IKK inhibition. Additionally, the patents disclose methods of treating such conditions and pharmaceutical compositions that include these innovative compounds.
Career Highlights
Karen J MacFarlane is currently associated with Signal Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and a focus on creating effective therapeutic solutions.
Collaborations
Some of her notable coworkers include Adam Kois and Yoshitaka Satoh, with whom she collaborates to further her research initiatives.
Conclusion
Karen J MacFarlane's contributions to pharmaceutical innovation, particularly in the area of IKK inhibitors, highlight her role as a leading inventor in her field. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes.